Peter Alf, PhD
Peter Alff is a Venture Partner at Orange Grove Bio ("OGB") based in New York City and brings nearly two decades of experience in biomedical science, startup operations, and venture capital investments with an emphasis on partnership building and venture creation with leading academic medical centers. Prior to joining Orange Grove Bio, Peter was Vice President of Partnerships at Owkin where he led partnership and business development efforts in the US. Previously, he was an Executive in Residence with Kairos Ventures where he focused on therapeutics investments and worked closely with scientists from top research universities to launch and manage numerous biotechnology companies as start-up CEO. Peter is also a former Business Development Manager for NYU’s Office of Therapeutics Alliances, where he facilitated company formation based on university technology across multiple areas within the life sciences and is a cofounder of Calder Biosciences, a protein-engineering and vaccine platform company, where he managed preclinical immunogen design and development and was Director of Strategic Initiatives.
Peter completed his postdoctoral training at The Rockefeller University, received his PhD in Molecular and Cellular Biology from Stony Brook University, and completed his undergraduate studies at Muhlenberg College where he received a B.S. degree in Biology.